Rural Health
Resources by Topic: Illicit drug use
Expanding the Opioid Use Disorder Medication Treatment Workforce in Rural Communities Through the RCORP Initiative
Examines the impact of the Rural Communities Opioid Response Program (RCORP) on the workforce supply of Drug Enforcement Administration (DEA)-waivered clinicians in rural areas, who are able to prescribe buprenorphine. Analyzes 2017–2022 DEA lists of waivered clinicians to report on counties with a waivered clinician, clinician-to-population ratios, and treatment slot-to-population ratios. Discusses the impact of RCORP funding on Opioid Use Disorder (OUD) recovery services in rural communities.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Kathleen Meyers, Davis G. Patterson
Citation: Journal of Rural Health
Date: 07/2024
Type: Document
view details
Examines the impact of the Rural Communities Opioid Response Program (RCORP) on the workforce supply of Drug Enforcement Administration (DEA)-waivered clinicians in rural areas, who are able to prescribe buprenorphine. Analyzes 2017–2022 DEA lists of waivered clinicians to report on counties with a waivered clinician, clinician-to-population ratios, and treatment slot-to-population ratios. Discusses the impact of RCORP funding on Opioid Use Disorder (OUD) recovery services in rural communities.
Author(s): C. Holly A. Andrilla, Sara C. Woolcock, Kathleen Meyers, Davis G. Patterson
Citation: Journal of Rural Health
Date: 07/2024
Type: Document
view details
Addressing Opioid Misuse through Community-Engaged Strategy Development: Study Protocol of a Randomized Controlled Trial
Describes the design of a research study to evaluate the effectiveness of the SEED Method and a modified Delphi method for the recruitment of participants to a community-based participatory research project. Study participants will develop strategies to respond to the opioid epidemic in three rural Virginia communities.
Author(s): Emily B. Zimmerman, Carlin Rafie, Sophie G. Wenzel, et al.
Citation: Research Involvement and Engagement, 10, 74
Date: 07/2024
Type: Document
view details
Describes the design of a research study to evaluate the effectiveness of the SEED Method and a modified Delphi method for the recruitment of participants to a community-based participatory research project. Study participants will develop strategies to respond to the opioid epidemic in three rural Virginia communities.
Author(s): Emily B. Zimmerman, Carlin Rafie, Sophie G. Wenzel, et al.
Citation: Research Involvement and Engagement, 10, 74
Date: 07/2024
Type: Document
view details
Risk Factors for Persistent Fatal Opioid-Involved Overdose Clusters in Massachusetts 2011–2021: A Spatial Statistical Analysis with Socio-Economic, Accessibility, and Prescription Factors
Examines locations with high opioid-involved overdose deaths in Massachusetts as well as factors contributing to mortality, such as social infrastructure and opioid prescribing practices. Provides state maps showing opioid overdose rates according to ZIP Code Tabulation Area (ZCTA). Includes data on social infrastructure access, opioid prescriptions, and ZCTA clusters, with breakdowns by poverty and race.
Author(s): Sumeeta Srinivasan, Jennifer Pustz, Elizabeth Marsh, Leonard D. Young, Thomas J. Stopka
Citation: BMC Public Health, 24, 1893
Date: 07/2024
Type: Document
view details
Examines locations with high opioid-involved overdose deaths in Massachusetts as well as factors contributing to mortality, such as social infrastructure and opioid prescribing practices. Provides state maps showing opioid overdose rates according to ZIP Code Tabulation Area (ZCTA). Includes data on social infrastructure access, opioid prescriptions, and ZCTA clusters, with breakdowns by poverty and race.
Author(s): Sumeeta Srinivasan, Jennifer Pustz, Elizabeth Marsh, Leonard D. Young, Thomas J. Stopka
Citation: BMC Public Health, 24, 1893
Date: 07/2024
Type: Document
view details
Prescription Opioid Tapering Practices and Outcomes at a Rural VA Health Care System
Presents a study on the clinical characteristics of rural veterans using opioids for chronic pain and undergoing opioid tapering. Breaks down data on outcomes from tapering for rural veterans who were taking 90 Morphine Equivalent Daily Dose (MEDD) or more. Highlights common tapering outcomes, such as increased pain, suicidal ideation, and other withdrawal symptoms.
Author(s): Rena Elizabeth Courtney, Emily Halsey, Tanvi Patil, et al.
Citation: Pain Medicine, 25(7), 480-482
Date: 07/2024
Type: Document
view details
Presents a study on the clinical characteristics of rural veterans using opioids for chronic pain and undergoing opioid tapering. Breaks down data on outcomes from tapering for rural veterans who were taking 90 Morphine Equivalent Daily Dose (MEDD) or more. Highlights common tapering outcomes, such as increased pain, suicidal ideation, and other withdrawal symptoms.
Author(s): Rena Elizabeth Courtney, Emily Halsey, Tanvi Patil, et al.
Citation: Pain Medicine, 25(7), 480-482
Date: 07/2024
Type: Document
view details
Community Buprenorphine Continuation Post-Release Following Extended Release Vs. Sublingual Buprenorphine During Incarceration: A Pilot Project in Maine
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
Type: Document
view details
Compares post-release outcomes among incarcerated people who received extended-release buprenorphine (XRB) versus sublingual buprenorphine (SLB) for opioid use disorder (OUD) in rural Maine jails. Includes data from two jails, one of which had implemented an XRB pilot program, on rates of post-release community buprenorphine treatment continuation, diversion, safety concerns, XRB side effects, and post-release mortality.
Author(s): Alane B. O'Connor, Catherine Gelsinger, Sadie M. Donovan, Jessica Marshall, Katherine A. Ahrens
Citation: Health & Justice, 12, 28
Date: 06/2024
Type: Document
view details
Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Describes the U.S. adult populations who need opioid use disorder (OUD) treatment, receive any OUD treatment, and receive medication for OUD. Includes data for metropolitan compared to micropolitan and noncore locations.
Author(s): Deborah Dowell, Samantha Brown, Shiromani Gyawali, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(25), 567-574
Date: 06/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Is Peer Support a Tipping Point for the Opioid Use Disorder Crisis in Appalachia? Research Holds the Answer
Investigates how the relationship among cultural, socioeconomic, medical, and geographic factors in Central Appalachia create additional burdens for opioid use recovery. Analyzes the effectiveness of medications for opioid use disorder and peer recovery support services, providing recommendations to address opioid use disorder in Appalachia.
Author(s): Kimberly Horn, Stephanie M. Mathis, Lara Nagle, et al.
Citation: Harm Reduction, 21, 122
Date: 06/2024
Type: Document
view details
Investigates how the relationship among cultural, socioeconomic, medical, and geographic factors in Central Appalachia create additional burdens for opioid use recovery. Analyzes the effectiveness of medications for opioid use disorder and peer recovery support services, providing recommendations to address opioid use disorder in Appalachia.
Author(s): Kimberly Horn, Stephanie M. Mathis, Lara Nagle, et al.
Citation: Harm Reduction, 21, 122
Date: 06/2024
Type: Document
view details
Attitudes Toward and Training in Medications for Opioid Use Disorders: A Descriptive Analysis among Employees in the Youth Legal System and Community Mental Health Centers
Results of a survey of 181 medications for opioid use disorder uptake (MOUD) professionals who work with youth legal system (YLS) and community mental health center (CMHC) settings in eight counties of a Midwestern state. Compares attitudes toward MOUD treatment, training, and workplace culture in rural versus urban areas, among CMHC versus YLS respondents, and more.
Author(s): Lauren M. O'Reilly, Katherine Schwartz, Steven A. Brown, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 19, 32
Date: 06/2024
Type: Document
view details
Results of a survey of 181 medications for opioid use disorder uptake (MOUD) professionals who work with youth legal system (YLS) and community mental health center (CMHC) settings in eight counties of a Midwestern state. Compares attitudes toward MOUD treatment, training, and workplace culture in rural versus urban areas, among CMHC versus YLS respondents, and more.
Author(s): Lauren M. O'Reilly, Katherine Schwartz, Steven A. Brown, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 19, 32
Date: 06/2024
Type: Document
view details
"I Don't Think That a Medication Is Going to Help Someone Long-Term Stay off Opioids": Treatment and Recovery Beliefs of Rural Vermont Family Members of People with Opioid Use Disorder
Examines beliefs related to opioid use disorder (OUD) treatment and recovery from the perspective of the family members of people with OUD. Analyzes interview data from 20 rural Vermont family members and discusses themes such as medication for OUD (MOUD), OUD treatment and mental health services, patient readiness for OUD treatment, and stigma.
Author(s): Catherine E. Peasley-Miklus, Julia G. Shaw, Katie Rosingana, et al.
Citation: Journal of Rural Health
Date: 06/2024
Type: Document
view details
Examines beliefs related to opioid use disorder (OUD) treatment and recovery from the perspective of the family members of people with OUD. Analyzes interview data from 20 rural Vermont family members and discusses themes such as medication for OUD (MOUD), OUD treatment and mental health services, patient readiness for OUD treatment, and stigma.
Author(s): Catherine E. Peasley-Miklus, Julia G. Shaw, Katie Rosingana, et al.
Citation: Journal of Rural Health
Date: 06/2024
Type: Document
view details
Facilitators and Barriers to Adopting or Expanding Medications for Opioid Use Disorder Provision in Rural Colorado Jails: a Qualitative Analysis
Reports findings of interviews with representatives of 7 rural Colorado jails on facilitators and barriers of medication for opioid use disorder (MOUD) adoption and expansion. Discusses factors including attitudes toward MOUD, collaborative partnerships, physical space, distance to services, provider availability, staff, and more.
Author(s): Heidi L. McNeely, Terri L. Schreiber, William L. Swann, Claudia R. Amura
Citation: Health and Justice, 12, 26
Date: 06/2024
Type: Document
view details
Reports findings of interviews with representatives of 7 rural Colorado jails on facilitators and barriers of medication for opioid use disorder (MOUD) adoption and expansion. Discusses factors including attitudes toward MOUD, collaborative partnerships, physical space, distance to services, provider availability, staff, and more.
Author(s): Heidi L. McNeely, Terri L. Schreiber, William L. Swann, Claudia R. Amura
Citation: Health and Justice, 12, 26
Date: 06/2024
Type: Document
view details